Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Bhatt, Deepak
Item TypeName
Academic Article Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
Academic Article Enhancing reperfusion therapy for myocardial infarction with dual antiplatelet therapy: Breaking the glass ceiling.
Academic Article Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial.
Academic Article Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators.
Academic Article Impaired myocardial perfusion score and inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction.
Academic Article Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
Academic Article Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting.
Academic Article What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Academic Article Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials.
Academic Article Scientific and therapeutic advances in antiplatelet therapy.
Academic Article Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.
Academic Article Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
Academic Article Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting.
Academic Article Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.
Academic Article The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: to what extent should the results be generalizable?
Academic Article Role of dual antiplatelet therapy in symptomatic patients with established vascular disease: putting the CHARISMA trial into therapeutic perspective.
Academic Article Clopidogrel with or without omeprazole in coronary artery disease.
Academic Article Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.
Academic Article Aspirin resistance: more than just a laboratory curiosity.
Academic Article Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
Academic Article Antiplatelet agents in patients undergoing percutaneous coronary intervention: how many and how much?
Academic Article Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
Academic Article Intensifying platelet inhibition--navigating between Scylla and Charybdis.
Academic Article Clinical trials update from the annual scientific session of the American College of Cardiology 2006.
Academic Article Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease.
Academic Article Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Academic Article Aspirin and clopidogrel resistance: an emerging clinical entity.
Academic Article Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
Academic Article P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease.
Academic Article Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk.
Academic Article Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Academic Article ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
Academic Article The expanding role of antiplatelet agents in coronary artery disease. A current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines.
Academic Article Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies.
Academic Article Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials.
Academic Article The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention.
Academic Article Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin?
Academic Article Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Academic Article Identification of and management approaches for the high-risk patient.
Academic Article Clinical aspects of platelet inhibitors and thrombus formation.
Academic Article Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention.
Academic Article Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
Academic Article Aspirin dose and six-month outcome after an acute coronary syndrome.
Academic Article Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial.
Academic Article Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial.
Academic Article High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial.
Academic Article An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
Academic Article Investigating the mechanisms of hyporesponse to antiplatelet approaches.
Academic Article Antiplatelet therapy and proton pump inhibition: cause for concern?
Academic Article Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter study.
Academic Article Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding.
Academic Article Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial.
Academic Article Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial.
Academic Article Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
Academic Article Bleeding complications during percutaneous coronary intervention.
Academic Article Platelet aspirin resistance in ED patients with suspected acute coronary syndrome.
Academic Article Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort.
Academic Article Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease.
Academic Article Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion.
Academic Article Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET).
Academic Article Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.
Academic Article Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.
Academic Article Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study.
Academic Article ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
Academic Article The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.
Academic Article Clopidogrel and risk for acute coronary events.
Academic Article Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.
Academic Article The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease.
Academic Article Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.
Academic Article Can clopidogrel and aspirin lower mortality in patients with acute myocardial infarction?
Academic Article Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial.
Academic Article Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers.
Academic Article Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
Academic Article ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Academic Article Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
Academic Article Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial.
Academic Article Patients with peripheral arterial disease in the CHARISMA trial.
Academic Article Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus.
Academic Article Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.
Academic Article Secondary prevention of stroke: can we do better than aspirin?
Academic Article Antiplatelet therapy in acute coronary syndromes.
Academic Article Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial.
Academic Article Apixaban with antiplatelet therapy after acute coronary syndrome.
Academic Article Drug-eluting stents: dual antiplatelet therapy for every survivor?
Academic Article Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.
Academic Article Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial).
Concept Aspirin
Academic Article Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51.
Academic Article Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
Academic Article Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial.
Academic Article Dual antiplatelet therapy after stent implantation--reply.
Academic Article Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events).
Academic Article Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists.
Academic Article Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy.
Academic Article Antiplatelet therapy: Defining the optimal duration of DAPT after PCI with DES.
Academic Article When Is a Double Better Than a TRIPLE?: Stenting in Patients With Atrial Fibrillation.
Academic Article Should patients stop taking aspirin for primary prevention?
Academic Article Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
Academic Article Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Academic Article Long-term use of ticagrelor in patients with prior myocardial infarction.
Academic Article The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.
Academic Article Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Academic Article Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial.
Academic Article Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
Academic Article Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
Academic Article Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention.
Academic Article Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Academic Article Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?
Academic Article Aspirin and proton-pump inhibitors: interpreting the interplay.
Academic Article Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
Academic Article Reply: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet Treatment.
Academic Article Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.
Academic Article Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Academic Article Response by Bagai et al to Letter Regarding Article, "Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention".
Academic Article Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.
Academic Article Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
Academic Article Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.
Academic Article Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
Academic Article Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.
Academic Article Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11?473 patients.
Academic Article Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.
Academic Article Letter by Taqueti and Bhatt Regarding Article, "Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study".
Academic Article Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention.
Academic Article Aspirin and the risk of cardiovascular events in atherosclerosis patients with and without prior ischemic events.
Academic Article Reply: Collapse of the Aspirin Empire: Is it Diabetic Gastroparesis or Cardioprotective Paresis?
Academic Article How I use laboratory monitoring of antiplatelet therapy.
Academic Article Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.
Academic Article Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis.
Academic Article Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
Academic Article Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Academic Article My Approach to the patient with CAD and aspirin resistance.
Academic Article Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
Academic Article International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies.
Academic Article Meta-Analysis of Aspirin Versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting.
Academic Article Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Academic Article Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
Academic Article External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry.
Academic Article Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-Analysis.
Academic Article Antiplatelet Therapy in Diabetes.
Academic Article Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry.
Academic Article Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial.
Academic Article 12 months of DAPT after acute coronary syndrome still beats 6 months.
Academic Article Lack of Association Between Heart Failure and Incident Cancer.
Academic Article Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?
Academic Article Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?
Academic Article Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention.
Academic Article Aspirin-still the GLOBAL LEADER in antiplatelet therapy.
Academic Article Will COMPASS Point to a New Direction in Thrombotic Risk Reduction in Patients With Stable Cardiovascular Disease?
Academic Article Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
Academic Article Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.
Academic Article Stroke Outcomes in the COMPASS Trial.
Academic Article Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.
Academic Article Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
Academic Article Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.
Academic Article Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
Academic Article Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease.
Academic Article The rise and fall of aspirin in the primary prevention of cardiovascular disease.
Academic Article Aspirin for Primary Prevention of Cardiovascular Events.
Academic Article Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54.
Academic Article Association of Multiple Enrichment Criteria With Ischemic and Bleeding Risks Among COMPASS-Eligible Patients.
Academic Article Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial.
Academic Article Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence study.
Academic Article Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Academic Article Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Academic Article Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis.
Academic Article Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin.
Academic Article Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.
Academic Article Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.
Academic Article Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes.
Academic Article Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.
Academic Article Comparison of the Effect of Age (< 75 Versus = 75) on the Efficacy and Safety of Dual Therapy (Dabigatran?+?Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin?+?Aspirin?+?Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial).
Academic Article Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation.
Academic Article Looking into the next decade of antithrombotic therapy for patients with atrial fibrillation and percutaneous coronary intervention.
Academic Article Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI).
Academic Article Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial.
Academic Article Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial.
Academic Article Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Academic Article Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI.
Academic Article Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
Academic Article Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry.
Academic Article Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis.
Academic Article Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or Is Reappraisal Warranted?
Academic Article Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.
Academic Article Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent.
Academic Article Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial.
Academic Article Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial.
Academic Article Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.
Academic Article The Future of Aspirin Therapy in Cardiovascular Disease.
Academic Article Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial.
Academic Article Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
Academic Article Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.
Academic Article Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial.
Academic Article Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure.
Search Criteria
  • Aspirin
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.